vs
Side-by-side financial comparison of DYNAVAX TECHNOLOGIES CORP (DVAX) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($104.1M vs $94.9M, roughly 1.1× DYNAVAX TECHNOLOGIES CORP). DYNAVAX TECHNOLOGIES CORP runs the higher net margin — 28.4% vs -1.4%, a 29.8% gap on every dollar of revenue. On growth, DYNAVAX TECHNOLOGIES CORP posted the faster year-over-year revenue change (17.7% vs 3.7%). Over the past eight quarters, DYNAVAX TECHNOLOGIES CORP's revenue compounded faster (30.6% CAGR vs 12.0%).
Dynavax Technologies Corp is a commercial-stage biopharmaceutical company specializing in the research, development, and production of innovative vaccines and immunotherapies for infectious diseases. Its lead approved product is Heplisav-B, an adult hepatitis B vaccine, with core markets in North America and Europe, alongside a pipeline of candidates addressing unmet public health needs.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
DVAX vs GDYN — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $94.9M | $104.1M |
| Net Profit | $26.9M | $-1.5M |
| Gross Margin | — | 34.8% |
| Operating Margin | 22.4% | 61.7% |
| Net Margin | 28.4% | -1.4% |
| Revenue YoY | 17.7% | 3.7% |
| Net Profit YoY | 53.0% | -150.6% |
| EPS (diluted) | $0.21 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.1M | ||
| Q4 25 | — | $106.2M | ||
| Q3 25 | $94.9M | $104.2M | ||
| Q2 25 | $95.4M | $101.1M | ||
| Q1 25 | $68.2M | $100.4M | ||
| Q4 24 | $72.0M | $100.3M | ||
| Q3 24 | $80.6M | $87.4M | ||
| Q2 24 | $73.8M | $83.0M |
| Q1 26 | — | $-1.5M | ||
| Q4 25 | — | $306.0K | ||
| Q3 25 | $26.9M | $1.2M | ||
| Q2 25 | $18.7M | $5.3M | ||
| Q1 25 | $-96.1M | $2.9M | ||
| Q4 24 | $7.0M | $4.5M | ||
| Q3 24 | $17.6M | $4.3M | ||
| Q2 24 | $11.4M | $-817.0K |
| Q1 26 | — | 34.8% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 34.1% | ||
| Q1 25 | — | 36.8% | ||
| Q4 24 | — | 36.9% | ||
| Q3 24 | — | 37.4% | ||
| Q2 24 | — | 35.6% |
| Q1 26 | — | 61.7% | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | 22.4% | -0.2% | ||
| Q2 25 | 15.1% | -0.1% | ||
| Q1 25 | -34.7% | -2.0% | ||
| Q4 24 | -2.3% | 1.3% | ||
| Q3 24 | 12.5% | 2.4% | ||
| Q2 24 | 7.0% | 0.0% |
| Q1 26 | — | -1.4% | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | 28.4% | 1.1% | ||
| Q2 25 | 19.6% | 5.2% | ||
| Q1 25 | -141.0% | 2.9% | ||
| Q4 24 | 9.8% | 4.5% | ||
| Q3 24 | 21.8% | 4.9% | ||
| Q2 24 | 15.4% | -1.0% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | — | $0.01 | ||
| Q3 25 | $0.21 | $0.01 | ||
| Q2 25 | $0.14 | $0.06 | ||
| Q1 25 | $-0.77 | $0.03 | ||
| Q4 24 | $0.07 | $0.06 | ||
| Q3 24 | $0.12 | $0.05 | ||
| Q2 24 | $0.08 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $160.2M | $327.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $534.1M | $530.1M |
| Total Assets | $946.5M | $605.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $327.5M | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | $160.2M | $338.6M | ||
| Q2 25 | $99.1M | $336.8M | ||
| Q1 25 | $51.7M | $325.5M | ||
| Q4 24 | $95.9M | $334.7M | ||
| Q3 24 | $119.3M | $231.3M | ||
| Q2 24 | $112.5M | $256.0M |
| Q1 26 | — | $530.1M | ||
| Q4 25 | — | $542.1M | ||
| Q3 25 | $534.1M | $537.7M | ||
| Q2 25 | $494.2M | $532.2M | ||
| Q1 25 | $530.9M | $517.4M | ||
| Q4 24 | $596.8M | $517.8M | ||
| Q3 24 | $681.4M | $400.2M | ||
| Q2 24 | $642.8M | $388.4M |
| Q1 26 | — | $605.0M | ||
| Q4 25 | — | $612.9M | ||
| Q3 25 | $946.5M | $613.2M | ||
| Q2 25 | $918.4M | $608.9M | ||
| Q1 25 | $945.9M | $590.9M | ||
| Q4 24 | $986.3M | $592.2M | ||
| Q3 24 | $1.1B | $477.3M | ||
| Q2 24 | $1.0B | $443.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $33.8M | — |
| Free Cash FlowOCF − Capex | $32.6M | — |
| FCF MarginFCF / Revenue | 34.4% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | 1.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $80.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $9.9M | ||
| Q3 25 | $33.8M | $7.0M | ||
| Q2 25 | $23.4M | $14.4M | ||
| Q1 25 | $-19.6M | $9.4M | ||
| Q4 24 | $53.0M | $7.1M | ||
| Q3 24 | $19.5M | $9.2M | ||
| Q2 24 | $10.7M | $10.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $6.1M | ||
| Q3 25 | $32.6M | $2.9M | ||
| Q2 25 | $22.0M | $10.2M | ||
| Q1 25 | $-23.6M | $6.0M | ||
| Q4 24 | $49.5M | $4.4M | ||
| Q3 24 | $18.1M | $5.9M | ||
| Q2 24 | $9.9M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | 34.4% | 2.8% | ||
| Q2 25 | 23.0% | 10.1% | ||
| Q1 25 | -34.6% | 6.0% | ||
| Q4 24 | 68.8% | 4.4% | ||
| Q3 24 | 22.5% | 6.8% | ||
| Q2 24 | 13.5% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.6% | ||
| Q3 25 | 1.3% | 3.9% | ||
| Q2 25 | 1.5% | 4.1% | ||
| Q1 25 | 5.8% | 3.3% | ||
| Q4 24 | 4.8% | 2.6% | ||
| Q3 24 | 1.7% | 3.7% | ||
| Q2 24 | 1.1% | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.34× | ||
| Q3 25 | 1.26× | 5.92× | ||
| Q2 25 | 1.25× | 2.73× | ||
| Q1 25 | — | 3.21× | ||
| Q4 24 | 7.52× | 1.56× | ||
| Q3 24 | 1.11× | 2.15× | ||
| Q2 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
GDYN
Segment breakdown not available.
